Doses of chemotherapy cells anticancer drugs or radiation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Cell Line HCT116 Cells HT29 Cells MCF-7 Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases49

Radiation Injuries Neoplasms Breast Neoplasms Lung Neoplasms Radiation Injuries, Experimental Radiation Pneumonitis Neoplasm Recurrence, Local Neoplasms, Radiation-Induced Adenocarcinoma Brain Neoplasms Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Neoplasm Metastasis Colonic Neoplasms Carcinoma, Squamous Cell Head and Neck Neoplasms Colorectal Neoplasms Liver Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Neutropenia Vomiting Carcinoma Nausea Osteosarcoma Bone Neoplasms Neoplasms, Experimental Testicular Neoplasms Lymphoma Stomach Neoplasms Pancreatic Neoplasms Leukopenia Glioma Acute Radiation Syndrome Glioblastoma Recurrence Disease Progression Neoplasms, Germ Cell and Embryonal Lymphatic Metastasis Precursor Cell Lymphoblastic Leukemia-Lymphoma Sarcoma Melanoma Leukemia, Radiation-Induced Peritoneal Neoplasms Leukemia Radiodermatitis Leukemia P388 Stomatitis Germinoma

Chemicals and Drugs85

Antineoplastic Agents Doxorubicin Cisplatin Etoposide Cyclophosphamide Antineoplastic Agents, Phytogenic Paclitaxel Antibiotics, Antineoplastic Camptothecin Vinblastine Methotrexate Antimetabolites, Antineoplastic Organoplatinum Compounds Carboplatin Bleomycin Antineoplastic Agents, Alkylating Taxoids Drug Carriers Deoxycytidine Radiation-Sensitizing Agents P-Glycoprotein Daunorubicin Anthracyclines Mitomycin Mitoxantrone Platinum Ellipticines Ifosfamide Cytarabine Dacarbazine Prodrugs Platinum Compounds Radiation-Protective Agents Tumor Suppressor Protein p53 Enzyme Inhibitors Carmustine DNA Topoisomerases, Type II Antibodies, Monoclonal Melphalan Tumor Markers, Biological Topoisomerase I Inhibitors Plant Extracts Proto-Oncogene Proteins c-bcl-2 Antibodies, Monoclonal, Humanized Neoplasm Proteins Fluorouracil Nimustine Tegafur Angiogenesis Inhibitors DNA Caspases Lomustine Cobalt Radioisotopes Floxuridine Chlorambucil Caspase 3 Nanocapsules Multidrug Resistance-Associated Proteins Adjuvants, Pharmaceutic Topotecan Granulocyte Colony-Stimulating Factor Teniposide Razoxane Antiemetics Drugs, Investigational RNA, Messenger Recombinant Proteins Radiopharmaceuticals Protein Kinase Inhibitors DNA Adducts Mitomycins Topoisomerase II Inhibitors DNA-Binding Proteins Quinazolines RNA, Small Interfering Thiotepa Liposomes ATP-Binding Cassette Transporters Pyrazines Drug Combinations DNA, Neoplasm Bridged Compounds Topoisomerase Inhibitors Tubulin Modulators Intercalating Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment73

Antineoplastic Combined Chemotherapy Protocols Radiation Dosage Chemotherapy, Adjuvant Dose-Response Relationship, Radiation Combined Modality Therapy Drug Screening Assays, Antitumor Treatment Outcome Radiation Monitoring Drug Administration Schedule Radiotherapy Disease-Free Survival Neoadjuvant Therapy Radiotherapy Dosage Survival Analysis Neoplasm Staging Drug Delivery Systems Prognosis Survival Rate Xenograft Model Antitumor Assays Drug Carriers Radiation Injuries, Experimental Radiometry Radiotherapy, Adjuvant Clinical Trials as Topic Induction Chemotherapy Dose Fractionation Follow-Up Studies Inhibitory Concentration 50 Administration, Oral Drug Design Salvage Therapy Neoplasm Transplantation Drug Evaluation, Preclinical Prospective Studies Infusions, Intravenous Radiotherapy, Intensity-Modulated Neoplasms, Experimental Chemotherapy, Cancer, Regional Perfusion Radiotherapy, Conformal Molecular Targeted Therapy Hyperthermia, Induced Tumor Burden Tomography, X-Ray Computed Transplantation, Autologous Chemoradiotherapy Lethal Dose 50 Kaplan-Meier Estimate Cranial Irradiation Flow Cytometry Models, Biological Radiotherapy Planning, Computer-Assisted Transplantation, Heterologous Nanocapsules Blotting, Western Infusions, Intra-Arterial Drug Evaluation Palliative Care Drug Discovery Clinical Trials, Phase I as Topic Brachytherapy Immunohistochemistry Drug Therapy Feasibility Studies Whole-Body Irradiation Randomized Controlled Trials as Topic Body Burden Hematopoietic Stem Cell Transplantation Radiotherapy, High-Energy Radiation Hybrid Mapping Actuarial Analysis Positron-Emission Tomography Injections, Intravenous Tumor Stem Cell Assay

Phenomena and Processes35

Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Drug Resistance, Neoplasm Apoptosis Cell Survival Time Factors Gamma Rays Dose-Response Relationship, Drug Cosmic Radiation DNA Damage Cell Proliferation Drug Resistance, Multiple Drug Synergism Background Radiation Ultraviolet Rays Inhibitory Concentration 50 Cell Cycle Gene Expression Regulation, Neoplastic Molecular Structure Radiation Effects DNA Repair Signal Transduction Lethal Dose 50 Drug Resistance Cell Division X-Rays Cell Death Genes, MDR Drug Interactions DNA Adducts Mutation Structure-Activity Relationship

Disciplines and Occupations8

Radiation Oncology Drug Design Nanomedicine Drug Discovery Medical Oncology Immunohistochemistry Radiobiology Pharmacogenetics

Technology, Industry, Agriculture4

Nanoparticles Nanomedicine Nanocapsules Liposomes

Information Science4

Survival Rate Radiotherapy, Intensity-Modulated Radiotherapy, Conformal Radiotherapy Planning, Computer-Assisted

Health Care26

Radiation Dosage Radiation Injuries Dose-Response Relationship, Radiation Treatment Outcome Radiation Monitoring Radiation Protection Disease-Free Survival Survival Analysis Survival Rate Radiation Injuries, Experimental Cosmic Radiation Clinical Trials as Topic Follow-Up Studies Ultraviolet Rays Radiation Effects Prospective Studies Kaplan-Meier Estimate Acute Radiation Syndrome Palliative Care Radioactive Hazard Release Clinical Trials, Phase I as Topic Feasibility Studies Randomized Controlled Trials as Topic Body Burden Relative Biological Effectiveness Actuarial Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Radiation Dosage Chemotherapy, Adjuvant Radiation, Ionizing Radiation Injuries Doxorubicin Cisplatin Dose-Response Relationship, Radiation Combined Modality Therapy Neoplasms Radiation Tolerance Cell Line, Tumor Drug Screening Assays, Antitumor Radiation Treatment Outcome Drug Resistance, Neoplasm Radiation Monitoring Radiation Protection Etoposide Cyclophosphamide Breast Neoplasms Antineoplastic Agents, Phytogenic Apoptosis Paclitaxel Antibiotics, Antineoplastic Drug Administration Schedule Cell Survival Radiotherapy Disease-Free Survival Lung Neoplasms Neoadjuvant Therapy Radiotherapy Dosage Survival Analysis Neoplasm Staging Time Factors Radiation Oncology Camptothecin Drug Delivery Systems Vinblastine Methotrexate Antimetabolites, Antineoplastic Prognosis Survival Rate Organoplatinum Compounds Tumor Cells, Cultured Carboplatin Xenograft Model Antitumor Assays Mice, Nude Bleomycin Antineoplastic Agents, Alkylating Taxoids Gamma Rays Dose-Response Relationship, Drug Drug Carriers Radiation Injuries, Experimental Radiation Pneumonitis Cosmic Radiation Deoxycytidine DNA Damage Neoplasm Recurrence, Local Radiometry Radiation-Sensitizing Agents Neoplasms, Radiation-Induced Adenocarcinoma Cell Proliferation P-Glycoprotein Drug Resistance, Multiple Daunorubicin Brain Neoplasms Drug Synergism Radiotherapy, Adjuvant Anthracyclines Clinical Trials as Topic Carcinoma, Non-Small-Cell Lung Ovarian Neoplasms Mitomycin Mitoxantrone Induction Chemotherapy Background Radiation Dose Fractionation Platinum Follow-Up Studies Neoplasm Metastasis Ellipticines Ifosfamide Ultraviolet Rays Cytarabine Inhibitory Concentration 50 Dacarbazine Colonic Neoplasms Cell Cycle Gene Expression Regulation, Neoplastic Carcinoma, Squamous Cell Molecular Structure Prodrugs Administration, Oral Platinum Compounds Radiation-Protective Agents Head and Neck Neoplasms

No FAQ available that match "doses of chemotherapy cells anticancer drugs or radiation"